Controversies in Uro-Oncology

5th International Symposium on Special Aspects of Radiotherapy, Berlin, May 2000

Cover

Editor(s): Wiegel, T. (Berlin)
Heicappell, R. (Berlin)
Miller, K. (Berlin)
Hinkelbein, W. (Berlin)

Status: available   
Publication year: 2002
Buy this book
Print Version : CHF 186.00, EUR 174.00, USD 219.00
Digital Version : CHF 186.00, EUR 174.00, USD 219.00

After ordering this title you will have access to the following digital version:

  • PDF (only downloadable by chapters)

Order this title
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.

This book belongs to
Frontiers of Radiation Therapy and Oncology , Vol. 36
Editor(s): Hinkelbein, W. (Berlin)
Meyer, J.L. (San Francisco, CA)
VIII + 196 p., 32 fig., 1 in color, 37 tab., hard cover, 2002
Status: available   
ISSN: 0071-9676
e-ISSN: 1662-3789

Current treatment strategies for bladder and prostate cancer
Over the past few years, tremendous progress has been made in the development of therapies for prostate and bladder cancer. As a consequence, greatly improved surgical techniques as well as new forms of radiotherapy, chemotherapy and hormonal therapy are now available.
This interdisciplinary approach is reflected in the broad scope of this volume, which aims to provide an overview of current treatment strategies for bladder and prostate cancer. The first part of the book discusses the optimization of radiation techniques like 3 D planning or IMRT and focuses on definitive radiotherapy with or without adjuvant or neoadjuvant hormonal manipulation. The quality of life after therapy is another important issue. Further chapters deal with radical cystectomy and organ preservation by radio-chemotherapy as well as the treatment of T1G3 cancer. In the last part, the emphasis lies on brachytherapy, which has become increasingly important for the treatment of prostate cancer.
This book will be of great value to urologists and radiation oncologists as well as to all others involved in the care of patients with urologic cancer.

Log in to MyKarger to check if you already have access to this title.


TOP